The Etiological Role of Allogeneic Fetal Rejection in Pre‐Eclampsia

Haruki Nishizawa, Kiyoshi Hasegawa, Machiko Suzuki, Shingo Kamoshida, Takema Kato, Kuniaki Saito, Yutaka Tsutsumi, Hiroki Kurahashi, Yasuhiro Udagawa

American Journal of Reproductive Immunology · 2007 · 39 citations · 29 references

Concepts

Abstract

PROBLEM: It has been demonstrated that allogeneic fetal rejection in normal pregnancy is prevented by placental indoleamine 2,3-dioxygenase (IDO). Further, an immunological etiology has been implicated in pre-eclampsia. METHOD OF STUDY: We examined the differences in placental IDO activity between normal and pre-eclamptic pregnancies. RESULTS: IDO mRNA expression and enzyme activity levels in the placenta were low in patients with severe pre-eclampsia. The enzyme activity also inversely correlates with the blood pressure of the patients. In the placentas from severe pre-eclampsia, IDO immunoreactivity was low, whereas regional T-cell infiltration was observed reciprocally proportional to the IDO activity. CONCLUSION: Our findings implicate a potential role for IDO activity and a maternal immunological reaction against an allogeneic fetus in the etiology of pre-eclampsia.

References

29